Myeloma and leukaemia trials.

Myeloma and leukaemia trials.

Bibliographic Details
Main Author:	Peto, R
Format:	Journal article
Language:	English
Published:	1972

Similar Items

Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
by: Eden, O, et al.
Published: (1991)

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
by: Shah, V, et al.
Published: (2020)

Letter: Chemoimmunotherapy of adult acute leukaemia.
by: Peto, R, et al.
Published: (1975)

The adapted Zelen was a feasible design to trial exercise in myeloma survivors
by: Land, J, et al.
Published: (2020)

Protein profiling in myeloma in vivo; Effects of bortezomib in a mouse model of myeloma
by: Edwards, C, et al.
Published: (2007)

Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand.
by: Shipman, C, et al.
Published: (2000)

Animal models of multiple myeloma
by: Olechnowicz, SWZ, et al.
Published: (2019)

Myeloma kidney: improving clinical outcomes?
by: Haynes, R, et al.
Published: (2012)

IS THE INCIDENCE OF MULTIPLE-MYELOMA REALLY INCREASING
by: Velez, R, et al.
Published: (1981)

Leukaemia.
by: Kinlen, L
Published: (1994)

Targeting Wnt signaling in myeloma in vivo; Differential effects on tumor burden and myeloma bone disease
by: Edwards, C, et al.
Published: (2007)

Bisphosphonates--mechanisms of action in multiple myeloma.
by: Shipman, C, et al.
Published: (2000)

Efek Antiproliferatif Pentagamavunon-O Terhadap Sel Myeloma: Atniproliferative Effect of Pentagamanunon-O on Myeloma Cells
by: Perpustakaan UGM, i-lib
Published: (2004)

Myeloma-induced alloreactive T cells arising in Myeloma-infiltrated bones include double-positive CD8(+)CD4(+) T cells: evidence from myeloma-bearing mouse model
by: Freeman, L.M., et al.
Published: (2011)

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma.
by: Shipman, C, et al.
Published: (2000)

Bone marrow adiposity and multiple myeloma
by: Morris, E, et al.
Published: (2018)

Advances in the management of myeloma bone disease.
by: Shipman, C, et al.
Published: (2005)

The pathogenesis of the bone disease of multiple myeloma.
by: Edwards, C, et al.
Published: (2008)

The Bone Marrow Microenvironment in Multiple Myeloma
by: Edwards, C
Published: (2010)

The role of BMP signalling in multiple myeloma
by: Gooding, S
Published: (2018)

Osteoprotegerin and the development of myeloma bone disease
by: Croucher, P, et al.
Published: (2004)

Chemotherapy of acute myeloid leukaemia in adults: Medical Research Council.
by: Cuckle, H, et al.
Published: (1979)

Sulforaphane - A new therapy for mutliple myeloma?
by: Locklin, R, et al.
Published: (2008)

Collaborative meta-analysis of randomised trials in chronic lymphocytic leukaemia (CLL)
by: Binet, J, et al.
Published: (1998)

Neonatal leukaemia
by: Roberts, I, et al.
Published: (2018)

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
by: Chessells, J, et al.
Published: (1994)

Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients.
by: Group, M
Published: (2001)

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials
by: Pasquali, S, et al.
Published: (1998)

Genomic patterns of progression in smoldering multiple myeloma
by: Bolli, N, et al.
Published: (2018)

Engineered nanomedicine for myeloma and bone microenvironment targeting
by: Swami, Archana, et al.
Published: (2015)

Host-derived MMP-7 decreases myeloma progression in vivo: An unexpected role for MMP-7 and osteopontin in myeloma pathogenesis
by: Lwin, S, et al.
Published: (2011)

Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.
by: Edwards, C, et al.
Published: (2007)

Bracken spores and leukaemia.
by: Cook-Mozaffari, P, et al.
Published: (1990)

Novel therapeutic targets in myeloma bone disease.
by: Webb, S, et al.
Published: (2014)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
by: Croucher, P, et al.
Published: (2003)

Wnt signaling: bone's defense against myeloma.
by: Edwards, C
Published: (2008)

BTK inhibition in myeloma: targeting the seed and the soil.
by: Edwards, C
Published: (2012)

The role of host microenvironment in the pathogenesis of multiple myeloma
by: Lwin, STS
Published: (2014)

Testing novel therapies for the treatment of multiple myeloma
by: Tosun, C
Published: (2023)

Bisphosphonates and in vivo models of multiple myeloma - Reply
by: Shipman, C, et al.
Published: (2001)